NCLX prevents cell death during adrenergic activation of the brown adipose tissue.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 07 2020
Historique:
received: 22 08 2018
accepted: 06 05 2020
entrez: 5 7 2020
pubmed: 6 7 2020
medline: 29 8 2020
Statut: epublish

Résumé

A sharp increase in mitochondrial Ca

Identifiants

pubmed: 32620768
doi: 10.1038/s41467-020-16572-3
pii: 10.1038/s41467-020-16572-3
pmc: PMC7334226
doi:

Substances chimiques

Adrenergic Agents 0
Mitochondrial Membrane Transport Proteins 0
Mitochondrial Permeability Transition Pore 0
Slc8b1protein, mouse 0
Sodium-Calcium Exchanger 0
Cyclosporine 83HN0GTJ6D
(melle-4)cyclosporin 96262S4I14
Calcium SY7Q814VUP
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

3347

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK099618
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK074778
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK063491
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Nedergaard, J. & Cannon, B. The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab. 11, 268–272 (2010).
pubmed: 20374959
Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277–359 (2004).
pubmed: 14715917
Divakaruni, A. S. & Brand, M. D. The regulation and physiology of mitochondrial proton leak. Physiology (Bethesda) 26, 192–205 (2011).
Nicholls, D. G. The physiological regulation of uncoupling proteins. Biochim. Biophys. Acta 1757, 459–466 (2006).
pubmed: 16725104
Territo, P. R., French, S. A., Dunleavy, M. C., Evans, F. J. & Balaban, R. S. Calcium activation of heart mitochondrial oxidative phosphorylation: rapid kinetics of mVO2, NADH, and light scattering. J. Biol. Chem. 276, 2586–2599 (2001).
pubmed: 11029457
Denton, R. M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta 1787, 1309–1316 (2009).
pubmed: 19413950
Drago, I., Pizzo, P. & Pozzan, T. After half a century mitochondrial calcium in- and efflux machineries reveal themselves. EMBO J. 30, 4119–4125 (2011).
pubmed: 21934651 pmcid: 3199396
Kwong, J. Q. & Molkentin, J. D. Physiological and pathological roles of the mitochondrial permeability transition pore in the heart. Cell Metab. 21, 206–214 (2015).
pubmed: 25651175 pmcid: 4616258
Nicholls, D. G. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta 1787, 1416–1424 (2009).
pubmed: 19298790 pmcid: 2752662
Szabó, I. & Zoratti, M. The mitochondrial megachannel is the permeability transition pore. J. Bioenerg. Biomembr. 24, 111–117 (1992).
pubmed: 1380498
Morciano, G. et al. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 78, 142–153 (2015).
pubmed: 25172387
Di Lisa, F., Menabo, R., Canton, M., Barile, M. & Bernardi, P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571–2575 (2001).
pubmed: 11073947
Bernardi, P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J. Biol. Chem. 267, 8834–8839 (1992).
pubmed: 1374381
Giorgio, V., Guo, L., Bassot, C., Petronilli, V. & Bernardi, P. Calcium and regulation of the mitochondrial permeability transition. Cell Calcium 70, 56–63 (2018).
pubmed: 28522037
Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341–345 (2011).
pubmed: 21685886 pmcid: 3486726
De Stefani, D., Raffaello, A., Teardo, E., Szabo, I. & Rizzuto, R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336–340 (2011).
pubmed: 21685888 pmcid: 4141877
Giorgi, C., Marchi, S. & Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 713–730 (2018).
pubmed: 30143745
Palty, R. et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl. Acad. Sci. USA 107, 436–441 (2010).
pubmed: 20018762
Gunter, T. E. & Pfeiffer, D. R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258, C755–C786 (1990).
pubmed: 2185657
Flicker, D., Sancak, Y., Mick, E., Goldberger, O. & Mootha, V. K. Exploring the in vivo role of the mitochondrial calcium uniporter in brown fat bioenergetics. Cell Rep. 27, 1364–1375.e5 (2019).
pubmed: 31042465 pmcid: 7231522
Al-Shaikhaly, M. H., Nedergaard, J. & Cannon, B. Sodium-induced calcium release from mitochondria in brown adipose tissue. Proc. Natl. Acad. Sci. USA 76, 2350–2353 (1979).
pubmed: 287079
Kostic, M. et al. PKA phosphorylation of NCLX reverses mitochondrial calcium overload and depolarization, promoting survival of PINK1-deficient dopaminergic neurons. Cell Rep. 13, 376–386 (2015).
pubmed: 26440884 pmcid: 4709126
White, N. & Burnstock, G. P2 receptors and cancer. Trends Pharmacol. Sci. 27, 211–217 (2006).
pubmed: 16530853
Koshimizu, T. A. et al. Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol. Pharmacol. 58, 936–945 (2000).
pubmed: 11040040
Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361, 315–325 (1993).
pubmed: 8381210
Patron, M. et al. MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity. Mol. Cell 53, 726–737 (2014).
pubmed: 24560927 pmcid: 3988891
Nita, I. I. et al. Pancreatic beta-cell Na+ channels control global Ca2+ signaling and oxidative metabolism by inducing Na+ and Ca2+ responses that are propagated into mitochondria. FASEB J. 28, 3301–3312 (2014).
pubmed: 24719357 pmcid: 6101212
Wikstrom, J. D. et al. Beta-cell mitochondria exhibit membrane potential heterogeneity that can be altered by stimulatory or toxic fuel levels. Diabetes 56, 2569–2578 (2007).
pubmed: 17686943
Giorgio, V. et al. Ca(2+) binding to F-ATP synthase beta subunit triggers the mitochondrial permeability transition. EMBO Rep. 18, 1065–1076 (2017).
pubmed: 28507163 pmcid: 5494526
Giorgio, V. et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. USA 110, 5887–5892 (2013).
pubmed: 23530243
Alavian, K. N. et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc. Natl. Acad. Sci. USA 111, 10580–10585 (2014).
pubmed: 24979777
Basso, E. et al. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280, 18558–18561 (2005).
pubmed: 15792954
Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).
pubmed: 15800627
Elrod, J. W. et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120, 3680–3687 (2010).
pubmed: 20890047 pmcid: 2947235
Waldmeier, P. C., Feldtrauer, J.-J., Qian, T. & Lemasters, J. J. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62, 22–29 (2002).
pubmed: 12065751
Antony, A. N. et al. MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration. Nat. Commun. 7, 10955 (2016).
pubmed: 26956930 pmcid: 4786880
Ye, L. et al. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 151, 96–110 (2012).
pubmed: 23021218 pmcid: 3477522
Chen, Y. et al. Crosstalk between KCNK3-mediated ion current and adrenergic signaling regulates adipose thermogenesis and obesity. Cell 171, 836–848.e13 (2017).
pubmed: 28988768 pmcid: 5679747
Sun, W. et al. Lack of TRPV2 impairs thermogenesis in mouse brown adipose tissue. EMBO Rep. 17, 383–399 (2016).
pubmed: 26882545 pmcid: 4772987
Ikeda, K. et al. UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat. Med. 23, 1454–1465 (2017).
pubmed: 29131158 pmcid: 5727902
Luongo, T. S. et al. The mitochondrial Na(+)/Ca(2+) exchanger is essential for Ca(2+) homeostasis and viability. Nature 545, 93–97 (2017).
pubmed: 28445457 pmcid: 5731245
Nedergaard, J., Wang, Y. & Cannon, B. Cell proliferation and anti-apoptosis: essential processes for recruitment of the full thermogenic capacity of brown adipose tissue. Biochim. Biophys. Acta https://doi.org/10.1016/j.bbalip.2018.06.013 (2018).
Oikonomou, E. K. & Antoniades, C. The role of adipose tissue in cardiovascular health and disease. Nat. Rev. Cardiol. 16, 83–99 (2019).
pubmed: 30287946
Mahdaviani, K. et al. Mfn2 deletion in brown adipose tissue protects from insulin resistance and impairs thermogenesis. EMBO Rep. 18, 1123–1138 (2017).
pubmed: 28539390 pmcid: 5887905
Cannon, B. & Nedergaard, J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J. Exp. Biol. 214, 242–253 (2011).
pubmed: 21177944
Momcilovic, M. et al. Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer. Cell Rep. 18, 601–610 (2017).
pubmed: 28099841 pmcid: 5260616
Loening, A. M. & Gambhir, S. S. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imaging 2, 131–137 (2003).
pubmed: 14649056
Cannon, B. & Nedergaard, J. Cultures of adipose precursor cells from brown adipose tissue and of clonal brown-adipocyte-like cell lines. Methods Mol. Biol. 155, 213–224 (2001).
pubmed: 11293074
Wikstrom, J. D. et al. Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure. EMBO J. 33, 418–436 (2014).
pubmed: 24431221 pmcid: 3983686
Benador, I. Y. et al. Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion. Cell Metab. 27, 869–885.e6 (2018).
pubmed: 29617645 pmcid: 5969538
Allen, G. F. G., Toth, R., James, J. & Ganley, I. G. Loss of iron triggers PINK1/Parkin‐independent mitophagy. EMBO Rep. 14, 1127–1135 (2013).
pubmed: 24176932 pmcid: 3981094
Assali, E. A. et al. Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in beta cells under lipotoxicity. FASEB J. Publ. Fed. Am. Soc. Exp. Biol. 33, 4154–4165 (2019).
Wu, M. et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292, C125–C136 (2007).
pubmed: 16971499
Jonkers, F. C. & Henquin, J. C. Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes 50, 540–550 (2001).
pubmed: 11246873
Wittig, I., Braun, H.-P. & Schagger, H. Blue native PAGE. Nat. Protoc. 1, 418–428 (2006).
pubmed: 17406264
Miller, N. et al. High-throughput image analysis of lipid-droplet-bound mitochondria. Preprint at https://www.biorxiv.org/content/10.1101/2020.03.10.985929v1 (2020).
Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
pubmed: 29203879 pmcid: 5715110

Auteurs

Essam A Assali (EA)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84103, Israel.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84105, Israel.

Anthony E Jones (AE)

Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Michaela Veliova (M)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Rebeca Acín-Pérez (R)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Mahmoud Taha (M)

Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84105, Israel.

Nathanael Miller (N)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Michaël Shum (M)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Marcus F Oliveira (MF)

Institute of Medical Biochemistry Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Guy Las (G)

Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84103, Israel.

Marc Liesa (M)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Israel Sekler (I)

Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84105, Israel. sekler@bgu.ac.il.

Orian S Shirihai (OS)

Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. Oshirihai@mednet.ucla.edu.
Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, 84103, Israel. Oshirihai@mednet.ucla.edu.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. Oshirihai@mednet.ucla.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH